Health
South African variant can ‘break through’ Pfizer vaccine, Israeli study says – Reuters
The coronavirus variant discovered in South Africa can “break through” Pfizer/BioNTech’s COVID-19 vaccine to some extent, a real-world data study in Israel found,…
By Maayan Lubell
JERUSALEM (Reuters) – The coronavirus variant discovered in South Africa can break through Pfizer/BioNTechs COVID-19 vaccine to some extent, a real-world data study in Israel found, though its prevalence in the country is low and the research has not been peer reviewed.
The study, released on Saturday, compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated patients…
-
Noosa News23 hours agoThe small patch of paddock emitting 10,000 cars’ worth of methane
-
Business23 hours agoDown more than 20% this year, does Macquarie rate Boss Energy shares a buy?
-
General24 hours agoKids unknowingly targeted with AI abuse apps, images
-
Business23 hours agoGuess which ASX 200 stock is rocketing on big US news